pubmed-article:15642808 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15642808 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:15642808 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:15642808 | lifeskim:mentions | umls-concept:C2350017 | lld:lifeskim |
pubmed-article:15642808 | lifeskim:mentions | umls-concept:C0532362 | lld:lifeskim |
pubmed-article:15642808 | lifeskim:mentions | umls-concept:C1704638 | lld:lifeskim |
pubmed-article:15642808 | lifeskim:mentions | umls-concept:C1883709 | lld:lifeskim |
pubmed-article:15642808 | lifeskim:mentions | umls-concept:C0330095 | lld:lifeskim |
pubmed-article:15642808 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:15642808 | pubmed:dateCreated | 2005-1-11 | lld:pubmed |
pubmed-article:15642808 | pubmed:abstractText | To describe the clinical, perimetric, and electroretinographic (ERG) results of 4 patients with cone dysfunction following irofulven treatment including the histopathologic and immunocytochemical features of one patient's retinas. | lld:pubmed |
pubmed-article:15642808 | pubmed:language | eng | lld:pubmed |
pubmed-article:15642808 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15642808 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:15642808 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15642808 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15642808 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15642808 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15642808 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15642808 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15642808 | pubmed:month | Jan | lld:pubmed |
pubmed-article:15642808 | pubmed:issn | 0003-9950 | lld:pubmed |
pubmed-article:15642808 | pubmed:author | pubmed-author:MilamAnn HAH | lld:pubmed |
pubmed-article:15642808 | pubmed:author | pubmed-author:GuptaNishaN | lld:pubmed |
pubmed-article:15642808 | pubmed:author | pubmed-author:SeidenMichael... | lld:pubmed |
pubmed-article:15642808 | pubmed:author | pubmed-author:LeeMichael... | lld:pubmed |
pubmed-article:15642808 | pubmed:author | pubmed-author:PensonRichard... | lld:pubmed |
pubmed-article:15642808 | pubmed:author | pubmed-author:LoewensteinJo... | lld:pubmed |
pubmed-article:15642808 | pubmed:author | pubmed-author:WepnerMeredit... | lld:pubmed |
pubmed-article:15642808 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15642808 | pubmed:volume | 123 | lld:pubmed |
pubmed-article:15642808 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15642808 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15642808 | pubmed:pagination | 29-34 | lld:pubmed |
pubmed-article:15642808 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:15642808 | pubmed:meshHeading | pubmed-meshheading:15642808... | lld:pubmed |
pubmed-article:15642808 | pubmed:meshHeading | pubmed-meshheading:15642808... | lld:pubmed |
pubmed-article:15642808 | pubmed:meshHeading | pubmed-meshheading:15642808... | lld:pubmed |
pubmed-article:15642808 | pubmed:meshHeading | pubmed-meshheading:15642808... | lld:pubmed |
pubmed-article:15642808 | pubmed:meshHeading | pubmed-meshheading:15642808... | lld:pubmed |
pubmed-article:15642808 | pubmed:meshHeading | pubmed-meshheading:15642808... | lld:pubmed |
pubmed-article:15642808 | pubmed:meshHeading | pubmed-meshheading:15642808... | lld:pubmed |
pubmed-article:15642808 | pubmed:meshHeading | pubmed-meshheading:15642808... | lld:pubmed |
pubmed-article:15642808 | pubmed:meshHeading | pubmed-meshheading:15642808... | lld:pubmed |
pubmed-article:15642808 | pubmed:meshHeading | pubmed-meshheading:15642808... | lld:pubmed |
pubmed-article:15642808 | pubmed:meshHeading | pubmed-meshheading:15642808... | lld:pubmed |
pubmed-article:15642808 | pubmed:meshHeading | pubmed-meshheading:15642808... | lld:pubmed |
pubmed-article:15642808 | pubmed:meshHeading | pubmed-meshheading:15642808... | lld:pubmed |
pubmed-article:15642808 | pubmed:meshHeading | pubmed-meshheading:15642808... | lld:pubmed |
pubmed-article:15642808 | pubmed:meshHeading | pubmed-meshheading:15642808... | lld:pubmed |
pubmed-article:15642808 | pubmed:meshHeading | pubmed-meshheading:15642808... | lld:pubmed |
pubmed-article:15642808 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:15642808 | pubmed:articleTitle | Cone damage in patients receiving high-dose irofulven treatment. | lld:pubmed |
pubmed-article:15642808 | pubmed:affiliation | Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44124, USA. leem4@ccf.org | lld:pubmed |
pubmed-article:15642808 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15642808 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:15642808 | pubmed:publicationType | Case Reports | lld:pubmed |
pubmed-article:15642808 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:15642808 | pubmed:publicationType | Multicenter Study | lld:pubmed |
pubmed-article:15642808 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |